Navigation Links
Northwestern Medicine Researchers Investigate New Stent Technology to Treat Coronary Artery Disease
Date:8/16/2013

CAD, coronary artery bypass surgery is sometimes necessary. A stent is a small, mesh coil that is either metal or coated with medications that help the artery remain open; these are known as drug eluting stents. The stent serves to help keep the artery open and decrease the chance of future blockages.

"Since the 1980s, these technologies have allowed many patients to avoid open heart surgery," said Ricciardi, who is also director of interventional cardiology at Northwestern Memorial and an associate professor at Northwestern University Feinberg School of Medicine. "While we've had great success with the current technology, once a stent is placed, it remains in the body forever. However, the stent support is really only needed for several months."

Absorb BVS is made of polylactide, a naturally dissolvable material that is commonly used in medical implants such as dissolving sutures. The device works by opening a clogged vessel and restoring blood flow to the heart similar to a drug eluting metallic stent, the current standard of care. Then unlike a permanent metallic stent, the Absorb BVS dissolves completely into the blood vessel, leaving behind only two pairs of tiny metallic markers which enable a physician to see where the device had been placed.  

With this study, researchers are seeking to understand the safety and effectiveness of the Absorb BVS in comparison to a traditional metallic stent.  The ABSORB III clinical trial will enroll approximately 2,250 subjects, the majority in the United States.

To learn more about the ABSORB III trial, please call the Bluhm Cardiovascular Institute Clinical Trials Unit (CTU) at 312-926-0840 or email kjordan@nmh.org.  

For more information on Northwestern's Bluhm Cardiovascular Institute, visit www.heart.nmh.org. To sche
'/>"/>

SOURCE Northwestern Memorial Hospital
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Companion Diagnostics Market Report - Streamlining Drug Development and Advancing Personalized Medicine
2. Premier Anti-Aging Network Ageology Expands into Illinois with Dr. Geoff Jones and Jones Institute for Advanced Medicine
3. University of Virginia Cancer Center Begins Using New Telemedicine Technology for Cervical Cancer Screenings
4. Cellular Biomedicine Group Appoints Director of Medical Research
5. UM Ventures Announces Collaboration Between UM School Of Medicines Dr. Frank Robb and Fina Biosolutions
6. Quartz Bio SA Supports Debiopharm Group Precision Medicine Bioinformatics
7. RIC to Launch New Era in Rehabilitation Medicine, Break Ground July 1 on New $550 Million Research Hospital
8. Sorrento Therapeutics and IGDRASOL to Present Late Stage Clinical Data Updates on their Oncology Nanomedicine Platform at the Joint Meeting of the European Foundation for Clinical Nanomedicine and European Technology Platform on Nanomedicine in Base
9. Stroke Treatment Based on Traditional Chinese Medicine Increases Chances of Recovery
10. Ibrutinib Phase 2 Study Results in Patients with Mantle Cell Lymphoma Published in The New England Journal of Medicine
11. Ibrutinib Study Results in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Published in The New England Journal of Medicine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... 2014  Humberto C. Antunes,  Galderma  worldwide CEO, will receive ... Journal of Drugs in Dermatology (JDD) at the ... event is January 17-20, 2014, at the Omni Orlando Resort at ... The ODAC is a distinguished event that delivers ...
(Date:1/15/2014)... 15, 2014  In an unprecedented effort to curb the spread of ... other transport vehicles, an advanced and portable UV germicidal lamp manufactured ... first time. In order to prevent EMS paramedics ... West Palm Beach Fire Rescue is the ...
(Date:1/15/2014)... Jan. 15, 2014  Echo Therapeutics, Inc. (Nasdaq: ... Symphony® CGM System as a non-invasive, wireless continuous glucose ... , Executive Chairman and Interim CEO of Echo Therapeutics, ... Annual Equity Conference. Mr. Doman will ...
Breaking Medicine Technology:Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 2Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 3Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 4Superbugs No Longer Ride In Rescue Vehicles 2Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 2Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 3
... BD (Becton, Dickinson and Company) (NYSE: ... of Waste Management, Inc. (NYSE: WM ), ... from hospitals and other healthcare facilities.  The companies are ... innovative service that will recycle medical sharps waste and ...
... -- The 109th Session Canton Fair will officially commence on ... conclude on May 5.   Buyers attending Canton ... China is upgrading its manufacturing industry, which will benefit ... exhibitors have invested significantly in R&D and development of their ...
Cached Medicine Technology:BD and Waste Management Launch Initiative to Recycle Medical Sharps 2BD and Waste Management Launch Initiative to Recycle Medical Sharps 3BD and Waste Management Launch Initiative to Recycle Medical Sharps 4Canton Fair: China's Greatest Trade Fair to Open in April 2
(Date:4/17/2014)... million older Americans suffer from depression, often brought on ... research a project that followed the lives of ... found that Internet use among the elderly can reduce ... , "That,s a very strong effect," said Shelia Cotten, ... and media who led the project. "And it all ...
(Date:4/17/2014)... April 17, 2014-- Colic affects about one in five ... numerous pediatric visits during the first several months after ... symptoms was showing promise; however, the April 1, 2014 ... Sung, Valerie) reported on a study, "Probiotics and Infant ... L reuteri for infant colic did not ...
(Date:4/17/2014)... Boston University School of Medicine (BUSM) have discovered ... in an experimental model. The findings, reported in ... Abuse , may lead to more effective treatments ... one of the leading causes of illness and ... economic impact by limiting the productivity of workers ...
(Date:4/17/2014)... (SACRAMENTO, Calif.) An international team led by researchers ... protein complex, which plays a key role in cell ... process. This is the first time the complex has ... could make cyclin B1/Cdk1 an excellent target to control ... medicine. The research was published online today in the ...
(Date:4/17/2014)... An international research team led by Cesar A. Arias, ... Center at Houston (UTHealth) has identified a new superbug ... The report appeared in the April 17 issue of ... The new superbug is part of a class of ... or MRSA, which is a major cause of hospital ...
Breaking Medicine News(10 mins):Health News:Internet use can help ward off depression among elderly 2Health News:New study says probiotic use for infant colic is not effective in reducing symptoms 2Health News:BUSM researchers find anti-seizure drug may reduce alcohol consumption 2Health News:Dual role: Key cell division proteins also power up mitochondria 2Health News:New MRSA superbug emerges in Brazil 2
... is open for the 2010 AIUM Annual Convention and ... United States dedicated to all disciplines of medical ultrasound, ... California. The 2010 Annual Convention focuses on emerging applications ... and manufacturers as ultrasound continues to advance and expand ...
... target for the most common form of ovarian cancer. ... the research team describes finding that a gene called MAGP2 ... was overexpressed in papillary serous ovarian tumors of patients who ... mechanisms by which MAGP2 may promote tumor growth. ...
... from high-flow oxygen treatment , TUESDAY, Dec. 8 ... effective treatment for cluster headaches, British researchers have found. ... as eight per day in bouts that last for ... the drug sumatriptan, but frequent use of the drug ...
... of death, recurrence , TUESDAY, Dec. 8 (HealthDay News) -- ... risk of death and cancer recurrence in women who,ve had ... between soy and a reduced risk of death held true ... tamoxifen, according to the study published in the Dec. 9 ...
... , STRONGSVILLE, Ohio, Dec. 8 ... way it conducts business and services customers earning an ISO ... management standard for organizations. The basis for the standard is ... a valued asset, information must be managed and protected from ...
... , SAN FRANCISCO, Dec. 8 Quantros, a leading ... published a whitepaper addressing the ramifications for healthcare organizations ... 2005 (PSQIA), the legislation that authorized the creation of ... providers contemplating participation in a PSO, Patient Safety ...
Cached Medicine News:Health News:AIUM gears up for 2010 Annual Convention in San Diego, California 2Health News:Possible ovarian cancer treatment target identified 2Health News:Oxygen Therapy May Relieve Cluster Headache Pain 2Health News:Soy Beneficial for Breast Cancer Survivors: Study 2Health News:Soy Beneficial for Breast Cancer Survivors: Study 3Health News:Antares Achieves ISO Certification 2Health News:Patient Safety Organization (PSO) Participation: What Every Provider Needs to Know 2
... telescoping plate design integrates the ... and vertebral column spacer. This ... need for supplemental fixation while ... bone graft to be delivered ...
... Tendril ST leads ... pacing leads, designed to ... reliability and flexibility to ... These pre-formed "J leads ...
The MYO-VAD is a novel cardiac support system with unique, life-saving features....
... revolutionary technology provides full picture ,CardioPAL ... incorporate true Artifi cial Intelligence, with a ... in the background, on each device. The ... activity based on rate, rhythm, morphology, and ...
Medicine Products: